Immunologic investigations into transgene directed immune-mediated myositis following delandistrogene moxeparvovec gene therapy.
Potter RA, Moeller IH, Khan S, Haegel H, Hollenstein A, Steiner G, Wandel C, Murphy AP, Asher DR, Palatinsky E, Griffin DA, Mason S, Iannaccone ST, Zaidman CM, Rodino-Klapac LR.
Potter RA, et al. Among authors: mason s.
Sci Rep. 2025 Jan 2;15(1):4. doi: 10.1038/s41598-024-84077-w.
Sci Rep. 2025.
PMID: 39747998
Free PMC article.
Clinical Trial.